Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-12-13FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
The FDA approved a supplemental application for Novo Nordisk’s insulin aspart protamine and insulin aspart mix 70/30.
-
FDA approval · 2012-12-13FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals' supplemental application for liraglutide, approving changes to the product's labeling.
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027) [Phase 1]
Phase 1 trial update reporting the safety and pharmacokinetics of single doses of MK-0941 in individuals with Type 2 diabetes; the study is …
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Effects of Sitagliptin on Postprandial Lipemia in Men With Type 2 Diabetes [Phase 3]
This Phase 3 trial studied the effect of sitagliptin on postprandial lipemia in men with Type 2 Diabetes Mellitus; results have been posted.
-
CLINICAL_TRIALS trial_result · 2012-12-11Clinical Trial Update: Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial evaluated the effect of a dietary intervention on weight change in subjects with Type 2 diabetes mellitus; results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2012-12-10Clinical Trial Update: Evaluation and Comparison of Noninvasive Blood Glucose Concentrations
Clinical trial update evaluating noninvasive blood glucose concentrations in people with diabetes and gestational diabetes; the current stat…
-
FDA approval · 2012-12-07FDA Approved: JANUVIA — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUVIA (sitagliptin) submitted by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Health Effects of Recreational Soccer in Type 2 Diabetic Men [NA]
A completed clinical trial evaluating the health effects of recreational soccer in men with type 2 diabetes, examining metabolic and cardiov…
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy [Phase 4]
This is a Phase 4 clinical trial evaluating the effects of ramipril and clopidogrel on oxidative stress, vascular inflammation, and endothel…
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166
Pulmonary function substudy in MannKind MKC-TI-161/162/166 trials has been terminated.
-
CLINICAL_TRIALS research · 2012-12-06Clinical Trial Update: Hypoglycemia- and Weight-related Quality of Life in Patients With Diabetes Mellitus Type 2 on Sulfonylurea Derivatives.
A terminated clinical trial update evaluating hypoglycemia- and weight-related quality of life in patients with type 2 diabetes treated with…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin. [NA]
A completed clinical trial from The Royal Bournemouth Hospital investigating how better control of diabetes affects a gut hormone that enhan…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Combined Nutritional and Exercise Strategies to Reduce Liver Fat Content in Patients With Type 2 Diabetes [NA]
This clinical trial update reports completion of a study on nutritional and exercise interventions aimed at reducing liver fat in patients w…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Japanese Phase 1 Multiple Ascending Dose Study [Phase 1]
Japanese Phase 1 multiple ascending dose study in Type 2 Diabetes Mellitus conducted by Bristol-Myers Squibb has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Lifestyle Intervention in Obese Non-diabetic Adults With a Family History of Diabetes. [NA]
A completed clinical trial update evaluates lifestyle interventions to prevent type 2 diabetes in obese, non-diabetic adults with a family h…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Evaluation of SCOUT DS in Subjects With Type 2 Diabetes #2
This Clinical Trial Update notes the completion of a study evaluating the SCOUT DS device in adults with Type 2 diabetes mellitus. The excer…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Evaluation of SCOUT DS Device in the Diagnosis of Diabetes Mellitus
This update reports the completion of a clinical trial evaluating VeraLight's SCOUT DS device for diagnosing Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Noninvasive Screening for Early Evidence of Diabetes With SCOUT DS
A completed clinical trial evaluating VeraLight's SCOUT DS noninvasive screening technology for early evidence of Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Evaluation of SCOUT DS in Subjects With Type 2 Diabetes
A completed clinical trial evaluating the SCOUT DS device in adults with type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Screening for Early Evidence of Diabetes
A completed clinical trial from VeraLight investigates screening methods for early evidence of type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Lancing Device Comparison Study
A completed clinical trial comparing a lancing device for self-monitoring blood glucose in adults with Type 1 or Type 2 diabetes. The study …
-
FDA approval · 2012-12-03FDA Approved: LIRAGLUTIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for liraglutide submitted by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: Biobehavioral Bases & Management of Type 2 Diabetes [NA]
A completed clinical trial from the University of Miami examined biobehavioral factors and management approaches for individuals with Type 2…
-
CLINICAL_TRIALS research · 2012-12-03Clinical Trial Update: The Impact of Omega-3 Supplementation on Gene Expression in Type 2 Diabetics [Phase 4]
A Phase 4 clinical trial update evaluating how omega-3 fatty acid supplementation affects gene expression in people with Type 2 diabetes mel…
-
CLINICAL_TRIALS research · 2012-11-28Clinical Trial Update: Mode of Action of Topiramate in the Treatment of Obese Patients With and Without Type 2 Diabetes Mellitus
This clinical trial update examines the mode of action of topiramate in obese patients with and without type 2 diabetes mellitus.